BIO Asia–Taiwan 2025 亞洲生技大會

BIO Asia–Taiwan 2025 亞洲生技大會

講師

Kang-yun, Lee

​​

Session 12– Advances in Genetics and Precision Medicine in Human Diseases  

Date:26 July (Friday)
Time10:45 – 10:50 (GMT+8)

Kang-yun, Lee

Executive Vice President
​​
Taipei Medical University
 

Dr. Kang-Yun Lee is Professor of Internal medicine and Vice President of Taipei Medical University (TMU). He also heads the Asthma Assembly of Asian Pacific Society of Respirology. Dr. Lee qualified his first degree of Medicine at TMU and received a PhD in clinical pharmacology at Imperial College London in 2006. 

Dr. Lee had been working on pathogenesis of asthma, COPD, and lung cancer. In addition to clinically orientated research, he has been working on molecular control of inflammation and immunity in lung diseases. He is interested in microenvironment and immune therapy for lung cancer. His lab identified a novel myeloid-derived suppressor cell (MDSC) in lung cancer, which has been implicated in tumor aggressiveness and drug resistance. Dr. Lee also participates in a great number of clinical trials, in variable lung diseases, including airways diseases, lung cancer and pneumonia.


Opening Remarks

.
 

​​